BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32961617)

  • 1. Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study.
    Piazza M; Hanssen NMJ; Persson F; Scheijen JL; van de Waarenburg MPH; van Greevenbroek MMJ; Rossing P; Hovind P; Stehouwer CDA; Parving HH; Schalkwijk CG
    Diabet Med; 2021 Sep; 38(9):e14405. PubMed ID: 32961617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher habitual intake of dietary dicarbonyls is associated with higher corresponding plasma dicarbonyl concentrations and skin autofluorescence: the Maastricht Study.
    Maasen K; Eussen SJPM; Scheijen JLJM; van der Kallen CJH; Dagnelie PC; Opperhuizen A; Stehouwer CDA; van Greevenbroek MMJ; Schalkwijk CG
    Am J Clin Nutr; 2022 Jan; 115(1):34-44. PubMed ID: 34625788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen.
    Scheijen JL; Schalkwijk CG
    Clin Chem Lab Med; 2014 Jan; 52(1):85-91. PubMed ID: 23492564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.
    Engelen L; Persson F; Ferreira I; Rossing P; Hovind P; Teerlink T; Stehouwer CD; Parving HH; Schalkwijk CG
    Nephrol Dial Transplant; 2011 Nov; 26(11):3573-7. PubMed ID: 21385863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria.
    Rabbani N; Adaikalakoteswari A; Rossing K; Rossing P; Tarnow L; Parving HH; Thornalley PJ
    Amino Acids; 2012 May; 42(5):1627-39. PubMed ID: 21384133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.
    Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Wirtz JJJM; Kooman JP; Schalkwijk CG
    PLoS One; 2019; 14(8):e0221058. PubMed ID: 31408493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the peripheral blood methylglyoxal levels in 10% of hospitalized chronic schizophrenia patients.
    Yoshioka S; Odani H; Furuhashi T; Tanaka T; Ogawa T
    Nagoya J Med Sci; 2021 Feb; 83(1):51-61. PubMed ID: 33727737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-Glucose Load Plasma α-Dicarbonyl Concentrations Are Increased in Individuals With Impaired Glucose Metabolism and Type 2 Diabetes: The CODAM Study.
    Maessen DE; Hanssen NM; Scheijen JL; van der Kallen CJ; van Greevenbroek MM; Stehouwer CD; Schalkwijk CG
    Diabetes Care; 2015 May; 38(5):913-20. PubMed ID: 25710921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel derivatization approach for simultaneous determination of glyoxal, methylglyoxal, and 3-deoxyglucosone in plasma by gas chromatography-mass spectrometry.
    Wu MY; Chen BG; Chang CD; Huang MH; Wu TG; Chang DM; Lee YJ; Wang HC; Lee CI; Chern CL; Liu RH
    J Chromatogr A; 2008 Sep; 1204(1):81-6. PubMed ID: 18692194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction.
    Odani H; Shinzato T; Matsumoto Y; Usami J; Maeda K
    Biochem Biophys Res Commun; 1999 Mar; 256(1):89-93. PubMed ID: 10066428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin, but Not Epicatechin, Decreases Plasma Concentrations of Methylglyoxal in Adults in a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial with Pure Flavonoids.
    Van den Eynde MDG; Geleijnse JM; Scheijen JLJM; Hanssen NMJ; Dower JI; Afman LA; Stehouwer CDA; Hollman PCH; Schalkwijk CG
    J Nutr; 2018 Dec; 148(12):1911-1916. PubMed ID: 30398646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Habitual Intake of Dietary Dicarbonyls is Associated with Greater Insulin Sensitivity and Lower Prevalence of Type 2 Diabetes: The Maastricht Study.
    Maasen K; Eussen SJPM; Dagnelie PC; Stehouwer CDA; Opperhuizen A; van Greevenbroek MMJ; Schalkwijk CG
    Am J Clin Nutr; 2023 Jul; 118(1):151-161. PubMed ID: 37054886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
    Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of autoantibodies against the angiotensin II type I receptor are not associated with serum dicarbonyl or AGE levels in patients with an aldosterone-producing adenoma.
    Piazza M; Hanssen NMJ; Scheijen JLJM; Vd Waarenburg M; Caroccia B; Seccia TM; Stehouwer CDA; Rossi GP; Schalkwijk CG
    J Hum Hypertens; 2023 Oct; 37(10):919-924. PubMed ID: 36418426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Habitual intake of dietary methylglyoxal is associated with less low-grade inflammation: the Maastricht Study.
    Maasen K; Eussen SJPM; Dagnelie PC; Houben AJHM; Webers CAB; Schram MT; Berendschot TTJM; Stehouwer CDA; Opperhuizen A; van Greevenbroek MMJ; Schalkwijk CG
    Am J Clin Nutr; 2022 Dec; 116(6):1715-1728. PubMed ID: 36055771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes.
    Han Y; Randell E; Vasdev S; Gill V; Gadag V; Newhook LA; Grant M; Hagerty D
    Mol Cell Biochem; 2007 Nov; 305(1-2):123-31. PubMed ID: 17594057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
    Alouffi S; Khan MWA
    Curr Protein Pept Sci; 2020; 21(9):890-898. PubMed ID: 31660813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method.
    Lapolla A; Flamini R; Dalla Vedova A; Senesi A; Reitano R; Fedele D; Basso E; Seraglia R; Traldi P
    Clin Chem Lab Med; 2003 Sep; 41(9):1166-73. PubMed ID: 14598866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia.
    Beisswenger PJ; Howell SK; O'Dell RM; Wood ME; Touchette AD; Szwergold BS
    Diabetes Care; 2001 Apr; 24(4):726-32. PubMed ID: 11315838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of dicarbonyl compounds in commonly consumed foods and drinks; presentation of a food composition database for dicarbonyls.
    Maasen K; Scheijen JLJM; Opperhuizen A; Stehouwer CDA; Van Greevenbroek MM; Schalkwijk CG
    Food Chem; 2021 Mar; 339():128063. PubMed ID: 33152865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.